浏览全部资源
扫码关注微信
1.广西中医药大学第一临床医学院,南宁 530022
2.广西中医药大学第一附属医院脑病科一区,南宁 530022
3.广西中医药大学研究生院,南宁 530200
Received:13 January 2025,
Revised:19 March 2025,
Accepted:2025-03-20,
Published:15 May 2025
移动端阅览
朱小敏,陈炜,符钰岚等.温脾通络开窍方抑制AD小鼠神经元坏死性凋亡的作用及机制 Δ[J].中国药房,2025,36(09):1046-1051.
ZHU Xiaomin,CHEN Wei,FU Yulan,et al.Effect of Wenpi tongluo kaiqiao formula against neuronal necroptosis in mice with Alzheimer’s disease and its mechanism[J].ZHONGGUO YAOFANG,2025,36(09):1046-1051.
朱小敏,陈炜,符钰岚等.温脾通络开窍方抑制AD小鼠神经元坏死性凋亡的作用及机制 Δ[J].中国药房,2025,36(09):1046-1051. DOI: 10.6039/j.issn.1001-0408.2025.09.05.
ZHU Xiaomin,CHEN Wei,FU Yulan,et al.Effect of Wenpi tongluo kaiqiao formula against neuronal necroptosis in mice with Alzheimer’s disease and its mechanism[J].ZHONGGUO YAOFANG,2025,36(09):1046-1051. DOI: 10.6039/j.issn.1001-0408.2025.09.05.
目的
2
基于Z-DNA结合蛋白1(ZBP1)/混合谱系激酶结构域样蛋白(MLKL)信号通路探讨温脾通络开窍方对阿尔茨海默病(AD)小鼠神经元坏死性凋亡的影响及机制。
方法
2
将40只
APP
/
PS1
转基因AD小鼠随机分为模型组,温脾通络开窍方低、高剂量组(10.4、20.8 g/kg,以生药量计)和盐酸多奈哌齐组(阳性对照,3 mg/kg),每组10只;并以10只C57BL/6J小鼠作为正常对照组。灌胃给药,每天1次,连续30 d。末次给药24 h后通过Morris水迷宫实验评估小鼠学习记忆能力,观察海马组织病理形态,检测血清中肿瘤坏死因子α(TNF-α)、白细胞介素4(IL-4)水平,检测海马组织中Tau蛋白、淀粉样前体蛋白(APP)和ZBP1/MLKL信号通路相关蛋白表达水平,检测海马组织神经元内磷酸化受体相互作用蛋白激酶3(p-RIPK3)阳性表达及海马组织中ZBP1 mRNA相对表达水平。
结果
2
与正常对照组比较,模型组小鼠第3~5天的逃避潜伏期均显著延长(
P
<0.05),穿越平台次数显著减少(
P
<0.05),海马组织出现明显病理性改变;TNF-α水平,APP、p-Tau、ZBP1蛋白表达水平和RIPK1、RIPK3、MLKL蛋白磷酸化水平,p-RIPK3荧光强度和ZBP1 mRNA相对表达水平均显著升高(
P
<0.05);血清中IL-4水平显著降低(
P
<0.05)。与模型组比较,各给药组小鼠上述指标水平均显著逆转(
P
<0.05),海马组织病理损伤减轻。
结论
2
温脾通络开窍方可通过抑制ZBP1/MLKL信号通路,减少AD小鼠神经元坏死性凋亡,抑制炎症反应,进而改善AD小鼠学习和空间记忆能力。
OBJECTIVE
2
To investigate the effects and mechanism of Wenpi tongluo kaiqiao formula (WPTL) against neuronal necroptosis in Alzheimer’s disease (AD) mice based on the Z-DNA binding protein 1 (ZBP1)/mixed lineage kinase domain-like protein (MLKL) signaling pathway.
METHODS
2
Forty
APP/PS1
transgenic AD mice were randomly divided into model group, WPTL low-dose (WPTL-L) group (10.4 g/kg, calculated by the raw medicine), WPTL high-dose (WPTL-H) group (20.8 g/kg, calculated by the raw medicine) and donepezil hydrochloride group (3 mg/kg), with 10 mice in each
group; another 10 C57BL/6J mice were selected as normal control group. Intragastric administration, once a day, for 30 consecutive days. Twenty-four hours after the last administration, Morris water maze test was performed to evaluate learning and memory abilities; the pathological morphology of hippocampal tissues was observed; the serum levels of tumor necrosis factor-α (TNF-α) and interleukin-4 (IL-4) were determined; the expressions of amyloid precursor protein (APP), Tau protein, and ZBP1/MLKL signaling pathway-related proteins in hippocampal tissues were detected; the positive expression of phosphorylated receptor-interacting protein kinase 3 (p-RIPK3) in the neurons of hippocampal tissues and mRNA expression of ZBP1 were measured in hippocampal tissues.
RESULTS
2
Compared with normal control group, the escape latency of mice in model group was prolonged significantly on day 3 to 5 (
P
<0.05), the times of crossing platform reduced significantly (
P
<0.05), and obvious pathological changes were observed in the hippocampal tissue. The level of TNF-α, the expressions of APP, p-Tau and ZBP1, the phosphorylation levels of RIPK1, RIPK3 and MLKL, the fluorescence intensity of p-RIPK3 as well as the mRNA expression of ZBP1 were significantly increased (
P
<0.05), while the serum level of IL-4 was decreased significantly (
P
<0.05). Compared with model group, above indexes were reversed significantly in administration groups (
P
<0.05), and pathological damage of hippocampal tissue was alleviated.
CONCLUSIONS
2
WPTL can inhibit the ZBP1/MLKL signaling pathway, reduce neuronal necroptosis in AD mice, and inhibit inflammatory responses, thereby improving learning and spatial memory abilities in AD mice.
ROSTAGNO A A . Pathogenesis of Alzheimer’s disease [J ] . Int J Mol Sci , 2022 , 24 ( 1 ): 107 .
SCHELTENS P , DE STROOPER B , KIVIPELTO M , et al . Alzheimer’s disease [J ] . Lancet , 2021 , 397 ( 10284 ): 1577 - 1590 .
TATULIAN S A . Challenges and hopes for Alzheimer’s disease [J ] . Drug Discov Today , 2022 , 27 ( 4 ): 1027 - 1043 .
陈炜 , 李兴峰 , 陈业文 , 等 . 温脾通络开窍方通过影响NF-κB通路改善阿尔兹海默症大鼠的认知功能研究 [J ] . 时珍国医国药 , 2021 , 32 ( 10 ): 2330 - 2333 .
CACCAMO A , BRANCA C , PIRAS I S , et al . Necroptosis activation in Alzheimer’s disease [J ] . Nat Neurosci , 2017 , 20 ( 9 ): 1236 - 1246 .
SCHWARZER R , JIAO H P , WACHSMUTH L , et al . FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells [J ] . Immunity , 2020 , 52 ( 6 ): 978 - 993.e6 .
GUO H , CHEN R , LI P , et al . ZBP1 mediates the progression of Alzheimer’s disease via pyroptosis by regulating IRF3 [J ] . Mol Cell Biochem , 2023 , 478 ( 12 ): 2849 - 2860 .
张重阳 , 于淼 , 陈荣昌 , 等 . 党参总皂苷对衰老小鼠认知功能障碍保护作用及机制 [J ] . 中国实验方剂学杂志 , 2024 , 30 ( 20 ): 70 - 76 .
杨惠丹 . 加味温脾通络开窍方治疗脾虚痰阻型阿尔茨海默病的临床疗效观察 [D ] . 南宁 : 广西中医药大学 , 2017 .
MANDREKAR-COLUCCI S , LANDRETH G E . Micro- glia and inflammation in Alzheimer’s disease [J ] . CNS Neurol Disord Drug Targets , 2010 , 9 ( 2 ): 156 - 167 .
ZHANG W K , ZHENG X H , GONG Y H , et al . VX-11e protects articular cartilage and subchondral bone in osteoarthritis by inhibiting the RIP1/RIP3/MLKL and MAPK signaling pathways [J ] . Bioorg Chem , 2022 , 120 : 105632 .
KOEHLER H , TITUS D , LAWSON C . Cell-type dependence of necroptosis pathways triggered by viral infection [J ] . FEBS J , 2024 , 291 ( 11 ): 2388 - 2404 .
OFENGEIM D , MAZZITELLI S , ITO Y , et al . RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease [J ] . Proc Natl Acad Sci USA , 2017 , 114 ( 41 ): E8788 - E8797 .
DEGTEREV A , OFENGEIM D , YUAN J Y . Targeting RIPK1 for the treatment of human diseases [J ] . Proc Natl Acad Sci USA , 2019 , 116 ( 20 ): 9714 - 9722 .
TU J L , CHEN W P , CHENG Z J , et al . EGb761 ameliorates cell necroptosis by attenuating RIP1-mediated mitochondrial dysfunction and ROS production in both in vivo and in vitro models of Alzheimer’s disease [J ] . Brain Res , 2020 , 1736 : 146730 .
0
Views
0
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution